Concord Biotech completes inspection by ministry of food and drug safety

Concord Biotech, listed on the National Stock Exchange of India Ltd and BSE Limited (Scrip Code: 543960), has announced that the MFDS (formerly KFDA) concluded its inspection of the company's API facility in Dholka. The inspection, which took place from February 18th to February 20th, 2025, was successfully completed. Concord Biotech stated that this achievement underscores their unwavering commitment to maintain world-class quality systems and standards and to deliver the highest quality products. The company believes this reinforces its position as a leader in the industry.